166 related articles for article (PubMed ID: 31734788)
1. Increased expression of plasminogen activator inhibitor-1 (PAI-1) is associated with depression and depressive phenotype in C57Bl/6J mice.
Girard RA; Chauhan PS; Tucker TA; Allen T; Kaur J; Jeffers A; Koenig K; Florova G; Komissarov AA; Gaidenko TA; Chamiso MB; Fowler J; Morris DE; Sarva K; Singh KP; Idell S; Idell RD
Exp Brain Res; 2019 Dec; 237(12):3419-3430. PubMed ID: 31734788
[TBL] [Abstract][Full Text] [Related]
2. Plasminogen Activator Inhibitor-1 (PAI-1) deficiency predisposes to depression and resistance to treatments.
Party H; Dujarrier C; Hébert M; Lenoir S; Martinez de Lizarrondo S; Delépée R; Fauchon C; Bouton MC; Obiang P; Godefroy O; Save E; Lecardeur L; Chabry J; Vivien D; Agin V
Acta Neuropathol Commun; 2019 Oct; 7(1):153. PubMed ID: 31610810
[TBL] [Abstract][Full Text] [Related]
3. The fibrinolytic system: A new target for treatment of depression with psychedelics.
Idell RD; Florova G; Komissarov AA; Shetty S; Girard RB; Idell S
Med Hypotheses; 2017 Mar; 100():46-53. PubMed ID: 28236848
[TBL] [Abstract][Full Text] [Related]
4. Potentiating effect of endothelial cells on astrocytic plasminogen activator inhibitor type-1 gene expression in an in vitro model of the blood-brain barrier.
Hultman K; Björklund U; Hansson E; Jern C
Neuroscience; 2010 Mar; 166(2):408-15. PubMed ID: 20060032
[TBL] [Abstract][Full Text] [Related]
5. Biphasic regulation of tissue plasminogen activator activity in ischemic rat brain and in cultured neural cells: essential role of astrocyte-derived plasminogen activator inhibitor-1.
Kim JW; Lee SH; Ko HM; Kwon KJ; Cho KS; Choi CS; Park JH; Kim HY; Lee J; Han SH; Ignarro LJ; Cheong JH; Kim WK; Shin CY
Neurochem Int; 2011 Feb; 58(3):423-33. PubMed ID: 21193004
[TBL] [Abstract][Full Text] [Related]
6. Modulation of BDNF cleavage by plasminogen-activator inhibitor-1 contributes to Alzheimer's neuropathology and cognitive deficits.
Gerenu G; Martisova E; Ferrero H; Carracedo M; Rantamäki T; Ramirez MJ; Gil-Bea FJ
Biochim Biophys Acta Mol Basis Dis; 2017 Apr; 1863(4):991-1001. PubMed ID: 28132883
[TBL] [Abstract][Full Text] [Related]
7. Endogenous plasminogen activator expression after embolic focal cerebral ischemia in mice.
Ahn MY; Zhang ZG; Tsang W; Chopp M
Brain Res; 1999 Aug; 837(1-2):169-76. PubMed ID: 10433999
[TBL] [Abstract][Full Text] [Related]
8. Antidepressant-like effect of n-3 PUFAs in CUMS rats: role of tPA/PAI-1 system.
Tang M; Jiang P; Li H; Cai H; Liu Y; Gong H; Zhang L
Physiol Behav; 2015 Feb; 139():210-5. PubMed ID: 25449400
[TBL] [Abstract][Full Text] [Related]
9. Is plasminogen activator inhibitor-1 a physiological bottleneck bridging major depressive disorder and cardiovascular disease?
Savoy C; Van Lieshout RJ; Steiner M
Acta Physiol (Oxf); 2017 Apr; 219(4):715-727. PubMed ID: 27246986
[TBL] [Abstract][Full Text] [Related]
10. Relation of depressive mood to plasminogen activator inhibitor, tissue plasminogen activator, and fibrinogen levels in patients with versus without coronary heart disease.
Lahlou-Laforet K; Alhenc-Gelas M; Pornin M; Bydlowski S; Seigneur E; Benetos A; Kierzin JM; Scarabin PY; Ducimetiere P; Aiach M; Guize L; Consoli SM
Am J Cardiol; 2006 May; 97(9):1287-91. PubMed ID: 16635597
[TBL] [Abstract][Full Text] [Related]
11. A long-acting PAI-1 inhibitor reduces thrombus formation.
Peng S; Xue G; Gong L; Fang C; Chen J; Yuan C; Chen Z; Yao L; Furie B; Huang M
Thromb Haemost; 2017 Jun; 117(7):1338-1347. PubMed ID: 28405670
[TBL] [Abstract][Full Text] [Related]
12. Vehicle-dependent Effects of Sphingosine 1-phosphate on Plasminogen Activator Inhibitor-1 Expression.
Takahashi C; Kurano M; Nishikawa M; Kano K; Dohi T; Miyauchi K; Daida H; Shimizu T; Aoki J; Yatomi Y
J Atheroscler Thromb; 2017 Sep; 24(9):954-969. PubMed ID: 28321011
[TBL] [Abstract][Full Text] [Related]
13. PAI-1 but Not PAI-2 Gene Deficiency Attenuates Ischemic Brain Injury After Experimental Stroke.
Griemert EV; Recarte Pelz K; Engelhard K; Schäfer MK; Thal SC
Transl Stroke Res; 2019 Aug; 10(4):372-380. PubMed ID: 29978354
[TBL] [Abstract][Full Text] [Related]
14. Plasminogen Activator Inhibitor-1 Protects Mice Against Cardiac Fibrosis by Inhibiting Urokinase-type Plasminogen Activator-mediated Plasminogen Activation.
Gupta KK; Donahue DL; Sandoval-Cooper MJ; Castellino FJ; Ploplis VA
Sci Rep; 2017 Mar; 7(1):365. PubMed ID: 28336948
[TBL] [Abstract][Full Text] [Related]
15. Rapid Increases in proBDNF after Pilocarpine-Induced Status Epilepticus in Mice Are Associated with Reduced proBDNF Cleavage Machinery.
Thomas AX; Cruz Del Angel Y; Gonzalez MI; Carrel AJ; Carlsen J; Lam PM; Hempstead BL; Russek SJ; Brooks-Kayal AR
eNeuro; 2016; 3(1):. PubMed ID: 27057559
[TBL] [Abstract][Full Text] [Related]
16. Plasminogen activator inhibitor-1 augments damage by impairing fibrinolysis after traumatic brain injury.
Griemert EV; Schwarzmaier SM; Hummel R; Gölz C; Yang D; Neuhaus W; Burek M; Förster CY; Petkovic I; Trabold R; Plesnila N; Engelhard K; Schäfer MK; Thal SC
Ann Neurol; 2019 May; 85(5):667-680. PubMed ID: 30843275
[TBL] [Abstract][Full Text] [Related]
17. A specific plasminogen activator inhibitor-1 antagonist derived from inactivated urokinase.
Gong L; Proulle V; Fang C; Hong Z; Lin Z; Liu M; Xue G; Yuan C; Lin L; Furie B; Flaumenhaft R; Andreasen P; Furie B; Huang M
J Cell Mol Med; 2016 Oct; 20(10):1851-60. PubMed ID: 27197780
[TBL] [Abstract][Full Text] [Related]
18. Impacts of aging and amyloid-β deposition on plasminogen activators and plasminogen activator inhibitor-1 in the Tg2576 mouse model of Alzheimer's disease.
Bi Oh S; Suh N; Kim I; Lee JY
Brain Res; 2015 Feb; 1597():159-67. PubMed ID: 25454795
[TBL] [Abstract][Full Text] [Related]
19. Plasminogen activator inhibitor type-1-deficient mice have an enhanced IFN-gamma response to lipopolysaccharide and staphylococcal enterotoxin B.
Renckens R; Pater JM; van der Poll T
J Immunol; 2006 Dec; 177(11):8171-6. PubMed ID: 17114493
[TBL] [Abstract][Full Text] [Related]
20. Plasminogen activator inhibitor-1 regulates macrophage-dependent postoperative adhesion by enhancing EGF-HER1 signaling in mice.
Honjo K; Munakata S; Tashiro Y; Salama Y; Shimazu H; Eiamboonsert S; Dhahri D; Ichimura A; Dan T; Miyata T; Takeda K; Sakamoto K; Hattori K; Heissig B
FASEB J; 2017 Jun; 31(6):2625-2637. PubMed ID: 28270519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
